Literature DB >> 25930174

Haemophilia A carriers experience reduced health-related quality of life.

L Gilbert1, A Paroskie1, D Gailani1, M R Debaun1, R F Sidonio2.   

Abstract

INTRODUCTION: Haemophilia A is an X-linked recessive bleeding disorder that primarily affects males. Emerging data support evidence for increased bleeding in female haemophilia A carriers despite factor VIII activity within the normal range. AIM: Data regarding the effect of increased bleeding on health-related quality of life (HR-QOL) in haemophilia A carriers is sparse. We tested the hypothesis that haemophilia A carriers have reduced HR-QOL related to bleeding symptoms.
METHODS: We conducted a cross-sectional study at Vanderbilt University. Case subjects were obligate or genetically verified haemophilia A carriers age 18-60 years. Control subjects were mothers of children with cancer who receive care at the Vanderbilt paediatric haematology-oncology clinic. Trained interviewers administered the Rand 36-Item Health Survey 1.0, a validated questionnaire evaluating eight health concepts that may affect HR-QOL, to each study participant. Mann-Whitney U-tests were used to compare median scores for the eight health domains between the case and control groups. RESULT: Forty-two haemophilia A carriers and 36 control subjects were included in analyses. Haemophilia A carriers had significantly lower median scores for the domains of 'Pain' (73.75 vs. 90; P = 0.02) and 'General health' (75 vs. 85; P = 0.01) compared to control subjects.
CONCLUSION: Haemophilia A carriers in our study demonstrated significantly lower median scores on the Rand 36-item Health Survey 1.0 in the domains of 'Pain' and 'General Health' compared to women in the control group. Our findings highlight the need for further investigation of the effect of bleeding on HR-QOL in this population.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Rand 36-item Health Survey 1.0; factor VIII deficiency; haemophilia carrier; health-related quality of life; short form 36 (SF-36); women with bleeding disorders

Mesh:

Year:  2015        PMID: 25930174      PMCID: PMC4619137          DOI: 10.1111/hae.12690

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  13 in total

1.  A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).

Authors:  A Tosetto; F Rodeghiero; G Castaman; A Goodeve; A B Federici; J Batlle; D Meyer; E Fressinaud; C Mazurier; J Goudemand; J Eikenboom; R Schneppenheim; U Budde; J Ingerslev; Z Vorlova; D Habart; L Holmberg; S Lethagen; J Pasi; F Hill; I Peake
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  Haemophilia A carriers demonstrate pathological and radiological evidence of structural joint changes.

Authors:  L Gilbert; L Rollins; M Hilmes; Y Luo; D Gailani; M R Debaun; R F Sidonio
Journal:  Haemophilia       Date:  2014-09-23       Impact factor: 4.287

4.  The RAND 36-Item Health Survey 1.0.

Authors:  R D Hays; C D Sherbourne; R M Mazel
Journal:  Health Econ       Date:  1993-10       Impact factor: 3.046

5.  Effects of haemophilic arthropathy on health-related quality of life and socio-economic parameters.

Authors:  K Fischer; J G Bom; E P Mauser-Bunschoten; G Roosendaal; H M Berg
Journal:  Haemophilia       Date:  2005-01       Impact factor: 4.287

6.  Quality of life during menstruation in patients with inherited bleeding disorders.

Authors:  R A Kadir; C A Sabin; D Pollard; C A Lee; D L Economides
Journal:  Haemophilia       Date:  1998-11       Impact factor: 4.287

7.  Bleeding in carriers of hemophilia.

Authors:  Iris Plug; Eveline P Mauser-Bunschoten; Annette H J T Bröcker-Vriends; Hans Kristian Ploos van Amstel; Johanna G van der Bom; Joanna E M van Diemen-Homan; José Willemse; Frits R Rosendaal
Journal:  Blood       Date:  2006-03-21       Impact factor: 22.113

8.  von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Authors:  W L Nichols; M B Hultin; A H James; M J Manco-Johnson; R R Montgomery; T L Ortel; M E Rick; J E Sadler; M Weinstein; B P Yawn
Journal:  Haemophilia       Date:  2008-03       Impact factor: 4.287

9.  Severe and moderate haemophilia A and B in US females.

Authors:  D M Di Michele; C Gibb; J M Lefkowitz; Q Ni; L M Gerber; A Ganguly
Journal:  Haemophilia       Date:  2014-03       Impact factor: 4.287

10.  A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.

Authors:  C A Janssen; P C Scholten; A P Heintz
Journal:  Obstet Gynecol       Date:  1995-06       Impact factor: 7.661

View more
  8 in total

Review 1.  Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.

Authors:  Gary Benson; Günter Auerswald; Gerry Dolan; Anne Duffy; Cedric Hermans; Rolf Ljung; Massimo Morfini; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2017-11-14       Impact factor: 3.443

2.  Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A.

Authors:  Christopher Stem; Christopher Rodman; Ritu M Ramamurthy; Sunil George; Diane Meares; Andrew Farland; Anthony Atala; Christopher B Doering; H Trent Spencer; Christopher D Porada; Graça Almeida-Porada
Journal:  Front Cell Dev Biol       Date:  2021-08-10

3.  Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review.

Authors:  Ateefa Chaudhury; Robert Sidonio; Nisha Jain; Elisa Tsao; Justyna Tymoszczuk; Mariana Oviedo Ovando; Roshni Kulkarni
Journal:  Haemophilia       Date:  2020-12-24       Impact factor: 4.287

Review 4.  Defining the Impact of Social Drivers on Health Outcomes for People with Inherited Bleeding Disorders.

Authors:  Karina Lopez; Keri Norris; Marci Hardy; Leonard A Valentino
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

5.  Challenges and knowledge gaps facing hemophilia carriers today: Perspectives from patients and health care providers.

Authors:  Megan Chaigneau; Monique Botros; Julie Grabell; Wilma Hopman; Paula James
Journal:  Res Pract Thromb Haemost       Date:  2022-09-20

6.  Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues.

Authors:  Angela C Weyand; Robert F Sidonio; Michelle Sholzberg
Journal:  Haemophilia       Date:  2022-05       Impact factor: 4.263

7.  Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study.

Authors:  Grace H Tang; Erin Norris; Jessica Petrucci; Paula D James; Adrienne Lee; Man-Chiu Poon; Georgina Floros; Laurence Boma-Fischer; Jerry Teitel; Rosane Nisenbaum; Michelle Sholzberg
Journal:  BMJ Open       Date:  2019-12-02       Impact factor: 2.692

8.  A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH.

Authors:  Karin P M van Galen; Roseline d'Oiron; Paula James; Rezan Abdul-Kadir; Peter A Kouides; Roshni Kulkarni; Johnny N Mahlangu; Maha Othman; Flora Peyvandi; Dawn Rotellini; Rochelle Winikoff; Robert F Sidonio
Journal:  J Thromb Haemost       Date:  2021-08       Impact factor: 16.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.